Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open 91ÌÒÉ« Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Organophosphates OPs) are extremely toxic compounds that are commonly used as pesticides and also as chemical warfare
nerve agents. OP compounds irreviserbilly inhibit neurotransmitter metabolizing enzyme, acetylcholinesterase (AChE).
Inhibition of AChE results in severe cholinergic crisis caused by increased concentration of acetylcholine at the cholinergic
nerve�nerve and nerve�muscle synapses. Some of the examples of toxic OPs are pesticides and chemical warfare nerve agents
like malathion, chlorpyrifos-oxon, parathion, soman, sarin, etc. The current treatment of OP-poisoning includes combination
of anti-cholinergic drugs together with quaternary oxime reactivators which is not much effective. Human paraoxonase 1
(hPON1), a 40 kDa enzyme predominantly found associated with HDL in the blood circulation, can potentially hydrolyze
numerous OPs and is thus considered as a promising catalytic scavenger candidate for the therapy of OP-poisoning. However,
the OP-hydrolyzing capacity of native hPON1 is low. In an attempt to increase the OP-hydrolyzing capacity, random mutagenesis
of recombinant human PON1 (rh-PON1) was carried out by both XL-1 Red mutator stain and error-prone PCR methods for
two rounds of molecular evolution. The protein was expressed, purified and characterized. Some of the mutant in the second
round of evolution showed 20-30 folds increase in OP-hydrolyzing activity. These novel mutants can be of therapeutic use
against OP-poisoning.